Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Oseltamivir Phosphate for Oral Suspension, 6 mg ...

Alembic Pharmaceuticals Limited is a leading research-driven, integrated pharmaceutical enterprise specialising in the development and manufacturing of generic formulations across diverse therapeutic ...

Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical ...

Bosutinib tablets are indicated for the treatment of adult patients with chronic phase Ph+ chronic myelogenous leukemia. Clobetasol propionate foam is indicated for the treatment of moderate to severe ...

Jul 19, 2026, 02:08 AM IST IST Alembic Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release Jul 11, 2026, 12:36 AM IST IST Alembic Pharma. - Specimen Copy Of The Letter Sent ...

SAN FRANCISCO--(BUSINESS WIRE)--Alembic, the leading holistic marketing attribution platform for enterprises, today announced it received $14 million in series A funding. The round was led by WndrCo, ...

Alembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 16,385.50 Crore) operating in Pharmaceuticals sector. Alembic Pharmaceuticals Ltd. key ...

Alembic Ltd., incorporated in the year 1907, is a Small Cap company (having a market cap of Rs 2,320.54 Crore) operating in Diversified sector. Alembic Ltd. key Products/Revenue Segments include ...

Alembic Pharmaceuticals Ltd. on Friday, June 26, said it has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Oseltamivir ...